Your browser doesn't support javascript.
loading
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia.
Andreeff, Michael; Kelly, Kevin R; Yee, Karen; Assouline, Sarit; Strair, Roger; Popplewell, Leslie; Bowen, David; Martinelli, Giovanni; Drummond, Mark W; Vyas, Paresh; Kirschbaum, Mark; Iyer, Swaminathan Padmanabhan; Ruvolo, Vivian; González, Graciela M Nogueras; Huang, Xuelin; Chen, Gong; Graves, Bradford; Blotner, Steven; Bridge, Peter; Jukofsky, Lori; Middleton, Steve; Reckner, Monica; Rueger, Ruediger; Zhi, Jianguo; Nichols, Gwen; Kojima, Kensuke.
Affiliation
  • Andreeff M; The University of Texas MD Anderson Cancer Center, Houston, Texas. mandreef@mdanderson.org.
  • Kelly KR; The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Yee K; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Assouline S; McGill University, Montreal, Quebec, Canada.
  • Strair R; Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey.
  • Popplewell L; City of Hope National Medical Center, Los Angeles, California.
  • Bowen D; St. James's Institute of Oncology, Leeds, United Kingdom.
  • Martinelli G; University of Bologna, Bologna, Italy.
  • Drummond MW; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.
  • Vyas P; University of Oxford, Oxford, United Kingdom.
  • Kirschbaum M; City of Hope National Medical Center, Los Angeles, California.
  • Iyer SP; The University of Texas Health Science Center at San Antonio, San Antonio, Texas.
  • Ruvolo V; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • González GM; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang X; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Chen G; Roche Innovation Center New York, New York.
  • Graves B; FORMA Therapeutics, Boston, Massachusetts.
  • Blotner S; Roche Innovation Center New York, New York.
  • Bridge P; Roche Innovation Center New York, New York.
  • Jukofsky L; Roche Innovation Center New York, New York.
  • Middleton S; Roche Innovation Center New York, New York.
  • Reckner M; Roche Innovation Center New York, New York.
  • Rueger R; Roche Innovative Center Penzberg, Penzberg, Germany.
  • Zhi J; Roche Innovation Center New York, New York.
  • Nichols G; Roche Innovation Center New York, New York.
  • Kojima K; The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 22(4): 868-76, 2016 Feb 15.
Article in En | MEDLINE | ID: mdl-26459177
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphoid / Imidazolines / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphoid / Imidazolines / Antineoplastic Agents Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: Estados Unidos